催眠疗法对肠易激综合征患者心理健康生活质量及疗效的影响

目的 探讨催眠治疗对肠易激综合征患者心理健康、生活质量及疗效的影响.方法 将符合罗马Ⅲ标准的78例肠易激综合征患者随机分为治疗组和对照组,治疗组除接受药物治疗外还进行每周1次、为期12周的催眠治疗,对照组仅接受药物治疗.评定2组焦虑白评量表(SAS)、抑郁自评量表(SDS)、特质应对方式问卷(TCSQ)、肠易激综合征生活质量量表(IBS-QOF)得分和临床疗效.结果 治疗后与对照组比较治疗组SAS和SDS评分均显著降低,分别为(37.20±12.46)分,(46.80±12.27)分,P<0.01;(39.83±10.36)分,(49.64±11.89)分,P<0.01];积极应对评分显著提高,消极应对评分显著降低,治疗组患者IBS-QOF总分和各分量表分值明显高于对照组(P<0.01),临床疗效明显优于对照组(P<0.01).结论 催眠治疗有助于减轻肠易激综合征患者的焦虑抑郁水平,改善不良应埘方式,提高患者的生命质量和疗效.

The influence of hypnotherapy on mental health, quality of life and clinical efficacy of patients with irritable bowel syndrome

Objective To explore the influence of hypnotherapy on mental health, quality of life and Clinical efficacy of patients with irritable bowel syndrome. Methods Seventy-eight irritable bowel syndrome ( IBS) patients were randomly divided into intervention group and control group. The two groups had the same medicinal treatment for 12 weeks. The intervention group were combined with hypnotherapy once a week. The scores of SDS, SAS, TCSQ, IBS-QOL (Irritable bowel syndrome-quality of life measure) questionnaire and clinical efficacy were evaluated between the two groups. Results Compared with control group the scores of SDS, SAS were statistically lower(37.20 ±12.46 vs 46.80 ± 12.27, P<0.01) , (39.83 ± 10.36 vs 49.64 ± 11.89, P<0.01).The score of passive coping mode were statistically lower while the score of positive coping mode were statistically higher. The overall score and all subscales scores of QOL were significantly higher (P < 0.05, respectively ). The evaluation of clinical efficacy were also significantly better than the control group(P<0.05). Conclusion Hypnotherapy effectively decrease anxiety and depression, changing unhelpful coping mode, improve quality of life and clinical efficacy of patients with irritable bowel syndrome.